Concepedia

Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study

Laura Valenzuela‐Vallejo, Pavlina Chrysafi, Matina Kouvari, Valentina Guatibonza-García, Sophia C. Mylonakis, Angeliki Katsarou, Ornella Verrastro, Georgios Markakis, Mohammed Eslam, Geltrude Mingrone,

Metabolism · 2023 · 33 citations · 44 references

DOI

Concepts

References

44

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations

, , +16

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association

Arteriosclerosis Thrombosis and Vascular Biology · 2022 · 645 citations

, , +17

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

Obesity Facts · 2016 · 519 citations · Full text

, , +11

GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance

Harding H. Luan, Andrew Wang, Brandon K. Hilliard et al. · Cell · 2019 · 509 citations · Full text

, , +12

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

Beth A. Davison, Stephen A. Harrison, Gad Cotter et al. · Journal of Hepatology · 2020 · 427 citations

, , +12